• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Psychotropic medications reduce further violent crimes in released prisoners

byDaniel FisherandMichael Milligan
November 4, 2016
in Chronic Disease, Psychiatry, Public Health
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. In this cohort study, released prisoners in Sweden who received antipsychotics, psychostimulants, and medications used in addictive disorders were less likely to commit a violent crime.

2. The rates of violent crimes were similar between patients who received psychotropic medications and those who were administered prison-based psychological treatments.

Evidence Rating Level: 2 (Good)

Study Rundown: With more than one third of released prisoners in the US and UK committing violent crimes, there remains a significant need for reducing these rates. As mental illness is overrepresented in prison populations, understanding how psychotropic medications may affect re-offense rates in released prisoners is essential. In this prospective cohort study, released prisoners from Sweeden who did and did not receive psychotropic medications were followed closely with rates of violent crimes recorded. For those who took antipsychotics, psychostimulants, or medications used to treat addictive disorders, the rate of violent crimes was reduced. However, those who received antidepressants or anti-epileptics did not show decreased violent crime rates. Similar results were found for those who were treated before and after release. In comparison, those who received psychological treatments showed similar reductions in violent crime rates.

As randomized controlled trials with violent crimes as an endpoint are hard to design and execute, the evidence in this study is very informative for those deciding on policies to reduce the rates of violent crimes after incarceration. However, the Swedish justice and prison system has many differences from other justice systems, especially those in the US, and so the generalizability of these results is hard to determine.

Click to read the study in JAMA

RELATED REPORTS

Teva: long acting olanzapine TEV’749 or Zyprexa shows success in schizophrenia

Machine-learning-based models found to have predictive abilities no better than chance in out-of-sample evaluations

Emraclidine is safe and well-tolerated for the treatment of schizophrenia

Relevant Reading: Antipsychotics, mood stabilisers, and risk of violent crime

In-Depth [cohort study]: A total of 22,275 prisoners released from Swedish prisons between 2005 and 2010 were tracked for a median of 4.6 years after release. Among all included in the study, 9915 received psychotropic medications and 5561 completed psychological programs. During follow-up, 4031 (18.1%) people were reconvicted for 5653 violent crimes. The between-individual analyses showed a reduction in violent crimes for prisoners who received antipsychotics (reduction of 21.7 violent crimes per 1000 person years; 95%CI 3.7 to 35.9). Similarly, those taking psychostimulants saw a reduction of 33.9 violent crimes per 1000 person years (95%CI 13.5 to 39.7) and those taking medications for addictive disorders saw a reduction of 27.5 violent crimes per 1000 person years (95%CI 7.0 to 41.6). Those who received antidepressants, antiepileptics, and adrenergic inhalants (negative control) did not show any differences from the un-medicated population. The within-individual analyses showed similar results, with 39.7 (95%CI 11.3 to 57.7) fewer violent offenses in total for antipsychotics, 42.8 for psychostimulants (95%CI2.2 to 67.6), and 36.4 (95%CI 2.1 to 54.0) for medications for addictive disorders. For psychological programs designed to prevent crime generally, the reduction in violent offenses was similar at 11.6 less violent crimes per 1000 person years (95%CI 5.1 to 17.1), and programs designed to treat substance abuse also reduced violent offenses by 23.2 (95%CI 10.3 to 34.1). Surprisingly, programs designed to reduce violent reoffending showed no differences in violent crime offenses.

Image: CC/Wiki

©2016 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

 

Tags: Antipsychoticprison
Previous Post

Antiretroviral therapy lowers mother-to-child HIV transmission rates

Next Post

The LRC-CPPT 1: Cholestyramine and coronary heart disease [Classics Series]

RelatedReports

Pharma

Teva: long acting olanzapine TEV’749 or Zyprexa shows success in schizophrenia

January 27, 2025
Childhood migraine associated with infantile colic
Psychiatry

Machine-learning-based models found to have predictive abilities no better than chance in out-of-sample evaluations

January 18, 2024
Majority of pediatric medication-related visits to emergency department are preventable
Chronic Disease

Emraclidine is safe and well-tolerated for the treatment of schizophrenia

December 28, 2022
Majority of pediatric medication-related visits to emergency department are preventable
Psychiatry

Variation in antipsychotic medication responsiveness present amongst schizophrenia patients

September 2, 2022
Next Post
Adverse pregnancy outcomes associated with thrombophilias [Classics Series]

The LRC-CPPT 1: Cholestyramine and coronary heart disease [Classics Series]

Flavored e-cigarette use associated with higher smoking risks in youth

Unmet healthcare need in adolescence linked to poor adult outcomes

Therapy advancements not correlated with improved health status for adult survivors of childhood cancer

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Personalized risk messages may not increase colorectal cancer screening uptake
  • Moderate to severe TBI is associated with elevated malignant brain tumor risk
  • 2 Minute Medicine Rewind September 1, 2025
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.